Dynamic Changes in Pancreatic Endocrine Cell Abundance, Distribution, and Function in Antigen-Induced and Spontaneous Autoimmune Diabetes

OBJECTIVE Insulin deficiency in type 1 diabetes and in rodent autoimmune diabetes models is caused by β-cell–specific killing by autoreactive T-cells. Less is known about β-cell numbers and phenotype remaining at diabetes onset and the fate of other pancreatic endocrine cellular constituents. RESEARCH DESIGN AND METHODS We applied multicolor flow cytometry, confocal microscopy, and immunohistochemistry, supported by quantitative RT-PCR, to simultaneously track pancreatic endocrine cell frequencies and phenotypes during a T-cell–mediated β-cell–destructive process using two independent autoimmune diabetes models, an inducible autoantigen-specific model and the spontaneously diabetic NOD mouse. RESULTS The proportion of pancreatic insulin-positive β-cells to glucagon-positive α-cells was about 4:1 in nondiabetic mice. Islets isolated from newly diabetic mice exhibited the expected severe β-cell depletion accompanied by phenotypic β-cell changes (i.e., hypertrophy and degranulation), but they also revealed a substantial loss of α-cells, which was further confirmed by quantitative immunohistochemisty. While maintaining normal randomly timed serum glucagon levels, newly diabetic mice displayed an impaired glucagon secretory response to non–insulin-induced hypoglycemia. CONCLUSIONS Systematically applying multicolor flow cytometry and immunohistochemistry to track declining β-cell numbers in recently diabetic mice revealed an altered endocrine cell composition that is consistent with a prominent and unexpected islet α-cell loss. These alterations were observed in induced and spontaneous autoimmune diabetes models, became apparent at diabetes onset, and differed markedly within islets compared with sub–islet-sized endocrine cell clusters and among pancreatic lobes. We propose that these changes are adaptive in nature, possibly fueled by worsening glycemia and regenerative processes.

[1]  S. Jayaraman A novel method for the detection of viable human pancreatic beta cells by flow cytometry using fluorophores that selectively detect labile zinc, mitochondrial membrane potential and protein thiols , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  R. Scharfmann,et al.  β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.

[3]  J. Kushner,et al.  Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes , 2006, Diabetes.

[4]  J. Krischer,et al.  Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. , 2006, Diabetes care.

[5]  Camillo Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Kushner,et al.  Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. , 2006, Diabetes.

[7]  K. Herold,et al.  Natural history of beta-cell function in type 1 diabetes. , 2005, Diabetes.

[8]  Alvin C. Powers,et al.  Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  E. Robinson,et al.  Histopathological Changes in Insulin, Glucagon and Somatostatin Cells in the Islets of NOD Mice During Cyclophosphamide-accelerated Diabetes: A Combined Immunohistochemical and Histochemical Study , 2005, Journal of Molecular Histology.

[10]  T. Aye,et al.  The pancreatic ductal epithelium serves as a potential pool of progenitor cells , 2004, Pediatric diabetes.

[11]  F. Cacciapaglia,et al.  The natural history of insulin content in the pancreas of female and male non‐obese diabetic mouse: implications for trials of diabetes prevention in humans , 2004, Diabetes/metabolism research and reviews.

[12]  M. Rewers,et al.  Redefining the clinical remission period in children with type 1 diabetes , 2004, Pediatric diabetes.

[13]  Yuval Dor,et al.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. , 2004, Nature.

[14]  W. Soeller,et al.  Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. , 2003, Diabetes.

[15]  H. Thomas,et al.  Fas Is Detectable on β Cells in Accelerated, But Not Spontaneous, Diabetes in Nonobese Diabetic Mice1 , 2003, The Journal of Immunology.

[16]  D. Harlan,et al.  Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes. , 2003, Journal of autoimmunity.

[17]  H. Thomas,et al.  Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice. , 2003, Journal of immunology.

[18]  D. D’Alessio,et al.  Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. , 2002, Diabetes.

[19]  B. Ahrén,et al.  Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice. , 2002, Metabolism: clinical and experimental.

[20]  E. Montanya,et al.  Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy. , 2000, Diabetes.

[21]  F. Karlsson,et al.  Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. , 2000, The Journal of endocrinology.

[22]  P. Halban,et al.  Sorting human beta-cells consequent to targeted expression of green fluorescent protein. , 1998, Diabetes.

[23]  R. Zinkernagel,et al.  Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.

[24]  R. Stein,et al.  Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. , 1997, Endocrinology.

[25]  G. Shulman,et al.  Time course of the defective α-cell response to hypoglycemia in diabetic BB rats , 1996 .

[26]  G. Shulman,et al.  Time course of the defective alpha-cell response to hypoglycemia in diabetic BB rats. , 1996, Metabolism: clinical and experimental.

[27]  M. Dardenne,et al.  Quantitative Immunohistochemical Changes in the Endocrine Pancreas of Nonobese Diabetic (NOD) Mice , 1995, Pancreas.

[28]  D. Harlan,et al.  Very-Low-Dose Streptozotocin Induces Diabetes in Insulin Promoter-mB7-1 Transgenic Mice , 1995, Diabetes.

[29]  D. Becker,et al.  Impaired Counterregulatory Hormone Responses to Hypoglycemia in Children and Adolescents with New Onset IDDM , 1994, The Journal of pediatric endocrinology.

[30]  L. Baxter,et al.  A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development , 1993, Diabetes.

[31]  G. Shulman,et al.  Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. , 1993, The Journal of clinical investigation.

[32]  J. Brown,et al.  Insulin secretion and islet endocrine cell content at onset and during the early stages of diabetes in the BB rat: effect of the level of glycemic control. , 1991, Canadian journal of physiology and pharmacology.

[33]  T. Jones,et al.  Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. , 1991, The Journal of clinical endocrinology and metabolism.

[34]  H. Pircher,et al.  Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.

[35]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[36]  J. Leahy,et al.  Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.

[37]  S. Bonner-Weir,et al.  Spontaneous Reassociation of Dispersed Adult Rat Pancreatic Islet Cells Into Aggregates With Three-Dimensional Architecture Typical of Native Islets , 1987, Diabetes.

[38]  D. Pipeleers,et al.  A new in vitro model for the study of pancreatic A and B cells. , 1985, Endocrinology.

[39]  P. Cryer,et al.  Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.

[40]  Marylou Ingram,et al.  Preparation of Rat Islet B-Cell-Enriched Fractions by Light-Scatter Flow Cytometry , 1982, Diabetes.

[41]  Å. Lernmark,et al.  Flow sorting of mouse pancreatic B cells by forward and orthogonal light scattering. , 1982, Cytometry.

[42]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[43]  J. Polak,et al.  Pathology of the endocrine pancreas. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  L. Orci,et al.  Glucagon: role in the hyperglycemia of diabetes mellitus. , 1975, Science.

[45]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.